GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Osteopore Ltd (ASX:OSX) » Definitions » Capex-to-Operating-Income

Osteopore (ASX:OSX) Capex-to-Operating-Income : 0.00 (As of Jun. 2024)


View and export this data going back to 2019. Start your Free Trial

What is Osteopore Capex-to-Operating-Income?

Capex-to-Operating-Income measures a company's investments in physical assets such as property, industrial buildings or equipment to its operating income.

Osteopore's Capital Expenditure for the six months ended in Jun. 2024 was A$-0.00 Mil. Its Operating Income for the six months ended in Jun. 2024 was A$-1.72 Mil.

GuruFocus do not calculate Capex-to-Operating-Income if the Operating Income is negative.


Osteopore Capex-to-Operating-Income Historical Data

The historical data trend for Osteopore's Capex-to-Operating-Income can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Osteopore Capex-to-Operating-Income Chart

Osteopore Annual Data
Trend Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Capex-to-Operating-Income
Get a 7-Day Free Trial - - - - -

Osteopore Semi-Annual Data
Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24
Capex-to-Operating-Income Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

Competitive Comparison of Osteopore's Capex-to-Operating-Income

For the Medical Instruments & Supplies subindustry, Osteopore's Capex-to-Operating-Income, along with its competitors' market caps and Capex-to-Operating-Income data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Osteopore's Capex-to-Operating-Income Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Osteopore's Capex-to-Operating-Income distribution charts can be found below:

* The bar in red indicates where Osteopore's Capex-to-Operating-Income falls into.



Osteopore Capex-to-Operating-Income Calculation

Osteopore's Capex-to-Operating-Income for the fiscal year that ended in Dec. 2023 is calculated as

Capex-to-Operating-Income=- Capital Expenditure / Operating Income
=- (-0.007) / -4.337
=N/A

Osteopore's Capex-to-Operating-Income for the quarter that ended in Jun. 2024 is calculated as

Capex-to-Operating-Income=- Capital Expenditure / Operating Income
=- (-0.002) / -1.716
=N/A

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Osteopore  (ASX:OSX) Capex-to-Operating-Income Explanation

Capex-to-Operating-Income assesses how much emphasis a company is placing upon investing in capital-intensive projects. The ratio is generally a good gauge to quantify how much focus on growth a company has. Typically, smaller companies that are still growing and expanding will have a higher Capex to Operating Income Ratio, since such businesses are likely investing more in physical assets. Lower ratios could indicate that a company has reached maturity and it is no longer pursuing aggressive growth.


Osteopore Capex-to-Operating-Income Related Terms

Thank you for viewing the detailed overview of Osteopore's Capex-to-Operating-Income provided by GuruFocus.com. Please click on the following links to see related term pages.


Osteopore Business Description

Traded in Other Exchanges
N/A
Address
191 Street Georges Terrace, Level 5, Perth, WA, AUS, 6000
Osteopore Ltd is engaged in the production of 3D-printed bioresorbable implants that are used in conjunction with surgical procedures to assist bone healing. Its products include Osteoplug, which is a bioresorbable implant used for covering trephination burr holes in neurosurgery, and Osteomesh which is a bioresorbable implant used in craniofacial surgery. Business operating segments are based on the firm's geographical presence in Singapore and Australia.

Osteopore Headlines

No Headlines